HomeBusinessHealthcareInnovation & Resilience of Biopharma Stocks
Innovation & Resilience of Biopharma Stocks

"The skilled healthcare worker shortage accelerated during the pandemic caused the next public health crisis. This is driving the need for more automation, A.I., digitization, and robotics. Some companies took off during the pandemic and are very well positioned to reap the benefits of that innovation moving forward," says Nina Deka. "Inflation should not affect the big biopharma group as much as most industries. Big biopharma firms see less than 1% of sales from Ukraine and Russia, making the war less impactful. Prescription drug demand is highly inelastic, which lends stability regardless of potential recessionary pressures," Damien Conover adds.

Trading 360

12 Jul 2022

ON AIR
11:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
ON AIR
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US